Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 5,136 shares at $23.53 ($121K) on 2025-02-12, disclosed to the SEC on 2025-02-12.
Open-market sale of $121k TVTX by CHIEF MEDICAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.53 | 2,568 | $60K | 50.0% |
| 2 | $23.53 | 2,568 | $60K | 50.0% |
| Total | $23.53 avg | 5,136 | $121K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |